Main description:

Attention deficit hyperactivity disorder (ADHD) is one of the most common mental disorders affecting children and adolescents. The condition is characterized by a persistent pattern of behavioural symptoms including inattentiveness, hyperactivity, and impulsiveness associated with substantial impairment in social, academic, and/or occupational functioning. Clinical and research interest in the topic of ADHD has grown substantially in recent years but, despite this,
there is still a lack of up-to-date reference texts devoted to the diagnosis, assessment, and management of patients with these conditions.

Part of the Oxford Textbooks in Psychiatry series, the Oxford Textbook of Attention Deficit Hyperactivity Disorder attempts to bridge this gap by providing an authoritative, multi-disciplinary guide to the latest research developments in the diagnosis, assessment, and management of patients with ADHD. Organized into eight key sections, this textbook covers the aetiology, pathophysiology, epidemiology, clinical presentation, co-morbidity, clinical assessment, and clinical
management of ADHD. Individual chapters address key topics such as the clinical assessment of ADHD in adults, and contain information on best practice, current diagnostic guidelines including DSM-5 and ICD-11, and key up-to-date references for further reading.

Edited and written by an international group of recognized experts, the Oxford Textbook of Attention Deficit Hyperactivity Disorder is a comprehensive resource suitable for child and adolescent psychiatrists, adult psychiatrists, and psychiatric trainees, as well as child psychologists, paediatricians, psychiatric nurses, and other mental health care professionals.

Contents:

SECTION I. Introduction
1: Eric Taylor: Development of the concept
2: Stephen P. Hinshaw and Richard M. Scheffler: ADHD in the 21st century: Biology, context, policy, and the need for integrative perspectives
SECTION II. Aetiology and pathophysiology
3: Kate Langley: ADHD genetics
4: Edmund-Sonuga-Barke and Gordon Harold: Conceptualizing and investigating the role of the environment in ADHD: Correlate, cause, consequence, context and treatment
5: Barbara Franke and Jan K. Buitelaar: Gene-environment interactions
6: Kerstin Konrad, Adriana di Martino, and Yuta Aoki: Brain volumes and intrinsic brain connectivity in ADHD
7: Katya Rubia: ADHD brain function
8: Philip Shaw and Eszter Szekely: Insights from neuroanatomic imaging into ADHD throughout the lifespan
9: Daniel Brandeis, Sandra Loo, Grainne McLoughlin, Hartmut Heinrich, and Tobias Banaschewski,: Neurophysiology
10: David Coghill, Maggie Toplak, Sinead Rhodes, and Nicoletta Adamo: Cognitive functioning in ADHD: Inhibition, memory, temporal discounting, decision making, timing, and reaction time variability
11: Celine Ryckaert, Jonna Kuntsi, and Philip Asherson: Emotional dysregulation and ADHD
12: Sarah O Neill, Jeffrey M. Halperin, and David Coghill: Neuropsychological functioning and ADHD: A developmental perspective
SECTION III. Epidemiology
13: Guilherme V. Polanczyk: Epidemiology
SECTION IV. Clinical Presentation
14: Luis Augusto Rohde, Christian Kieling, and Giovanni Abrahao Salum: Current diagnostic criteria: DSM, ICD, and future perspectives
15: Stephen P. Becker and Russell A. Barkley: Sluggish cognitive tempo
16: Corina U. Greven, Jennifer. S. Richards, and Jan K. Buitelaar: Sex differences in ADHD
17: Melissa Mulraney and David Coghill: Quality of life and impairment in ADHD
18: Marios Adamou: Adult ADHD and employment
19: Philip Asherson, Josep Antoni Ramos-Quiroga, and Susan Young: Adult ADHD: Clinical presentation and assessment
SECTION V. Comorbidity
20: Anita Thapar and Stephanie van Goozen: Conduct disorder in ADHD
21: Melissa Mulraney, Argyris Stringaris, and Eric Taylor: Irritability, disruptive mood, and ADHD
22: Cristal Oxley and Argyris Stringaris: Comorbidity: Depression and anxiety
23: Timothy Wilens, Nicholas Carrellas, and Joseph Biederman,: ADHD and substance misuse
24: Sven Boelte, Luise Poustka, and Hilde Geurts: Autism spectrum disorder
25: Emily Simonoff: Intellectual impairment and neurogenetic disorders
26: Aribert Rothenberger, Andreas Becker, Lillian-Geza Rothenberger, and Veit Roessner: Influence of tics and/or obsessive-compulsive behaviour on the phenomenology of ADHD
27: Christopher Gillberg, Elisabeth Fernell, I. Carina Gillberg, and Bjoern Kadesjoe: Developmental coordination disorder
28: Rosemary Tannock: ADHD and communication disorders
29: Erik G. Willcutt: ADHD and reading disorder
30: Melissa Mulraney, Emma Sciberras, and Michel Lecendreux: ADHD and sleep
31: Samuele Cortese and Marcel Romanos: The relationship of ADHD to obesity and allergy
SECTION VI. Clinical Assessment
32: Marina Danckaerts and David Coghill: Children and adolescents: Assessment in everyday clinical practice
33: Sandra Kooij, Philip Asherson, and Michael Roesler: ADHD in adults, assessment issues
SECTION VII. Interventions
34: Jim Swanson: Long-term outcomes in the multimodal treatment study of children with ADHD
35: David Daley and Saskia Van der Oord: Behavioural interventions for preschool ADHD
36: Manfred Doepfner and Saskia van der Oord: Cognitive-behavioural treatment in childhood and adolescence
37: Alexandra Philomena Lam and Alexandra Philipsen: Behavioural (adolescent / adult)
38: Edmund Sonuga-Barke and Samuele Cortese: Cognitive training approaches for ADHD: Can they be made more effective?
39: Martin Holtmann, Bjoern Albrecht, and Daniel Brandeis: Neurofeedback
40: Jan K. Buitelaar, Nanda Rommelse, Verena Ly, and Julia J. Rucklidge: Nutritional intervention for ADHD
41: Alessandro Zuddas, Tobias Banaschewski, David Coghill, and Mark A. Stein: ADHD treatment: Psychostimulants
42: Ralf W. Dittmann, Alexander Hage, Juan D. Pedraza, and Jeffrey H. Newcorn: Non-stimulants in the treatment of ADHD
43: Chris Hollis: ADHD and transitions to adult mental health services
44: Christine Merrell and Kapil Sayal: ADHD and school
SECTION VIII. Clinical Management
45: David Coghill and Marina Danckaerts: Organizing and delivering treatment for ADHD
46: Philip Asherson and Josep Antoni Ramos-Quiroga: Treatment in Adult ADHD
47: David Coghill, Alessandro Zuddas, Luis Augusto Rohde, and Tobias Banaschewski: The next steps: Future clinical and research developments in ADHD